Biologics in oral medicine: principles of use and practical considerations. - Wikidata - awgldk - TriplyDB

Biologics in oral medicine: principles of use and practical considerations.

Biologics in oral medicine: principles of use and practical considerations.

http://www.wikidata.org/entity/Q37993932

about

Mucous membrane pemphigoid Biologics in oral medicine: oral Crohn's disease and orofacial granulomatosis Biologics in oral medicine: ulcerative disorders.Biologics in oral medicine: Sjogren syndrome.Systemic use of non-biologic corticosteroids in orofacial diseases.Orofacial adverse effects of biological agents.Biological agents: what they are, how they affect oral health and how they can modulate oral healthcare.

P2860

Q27691456-0632870B-B4E2-44E9-B6CA-1DA27AF90AAD Q28261955-A5B29E1C-48F8-4A13-9EDD-A0F06A273C57 Q37999475-3CD2A418-196A-40F0-BF92-6F52680051FB Q38002156-844EA99A-C7CC-4398-BC65-B5F3AB6672AC Q38112826-3BBC777A-EDC2-4774-BED7-FC3C99410893 Q38213692-2B06703C-28CC-4ECB-9A8A-CD12810513B2 Q38538490-B6785300-7613-45DA-8F13-5897744DE062

P2860

Biologics in oral medicine: principles of use and practical considerations.

http://www.wikidata.org/entity/Q37993932

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biologics in oral medicine: principles of use and practical considerations.

@en

Biologics in oral medicine: principles of use and practical considerations.

@nl

type

label

Biologics in oral medicine: principles of use and practical considerations.

@en

Biologics in oral medicine: principles of use and practical considerations.

@nl

prefLabel

Biologics in oral medicine: principles of use and practical considerations.

@en

Biologics in oral medicine: principles of use and practical considerations.

@nl

P1433

Q37993932-EEF5553D-686F-4183-A57E-7CC249F63196

P1476

Q37993932-5BC61F82-3C8B-43F2-B12C-F26184DE784F

P2093

Q37993932-32C2EA13-B066-4EF6-B01A-091DD43D7599

Q37993932-F8BDCA68-AEDC-4C91-910D-D58D9F38EFF8

P2860

Q37993932-0018B5D9-ECA7-4FA1-A2A8-DBC876E15066

Q37993932-01353516-C5D5-4DFB-AFFB-CB494BA74186

Q37993932-01E124BA-4C3E-4052-B201-B985B7E9EC32

Q37993932-023DC583-3468-482F-BE92-ABB6BF7EC661

Q37993932-05B4EBAC-FD50-4019-B5A6-75FC7B0FAE71

Q37993932-079AF125-6FEC-4C03-975F-168B147F6F55

Q37993932-082C0E71-E1DF-46F8-8677-11B91BEE2F5F

Q37993932-0F4B3FC8-44FB-4655-B206-084896A3419F

Q37993932-0FC9C3AB-6F43-4010-9895-ACF2543C544C

Q37993932-113A55A7-CD6A-426A-B393-2006DDF1900D

P304

Q37993932-83F1188B-40B8-4C37-AF9C-493AB5AF693E

P31

Q37993932-DC310F11-3801-441A-BD41-1BA9B98F63FE

P356

Q37993932-CFE974F1-EA3F-4CFF-A1C9-BDBDC5F9F061

P433

Q37993932-F9292315-B68E-40CF-80A8-77DC4598400D

P478

Q37993932-25BBB028-4A12-4927-9565-330611E585D1

P577

Q37993932-04A146C7-9979-4E27-9486-F7CDE54D7278

P5875

Q37993932-287C34D5-A999-4C3D-B8CF-995B3A283A47

P698

Q37993932-9BDA61BF-CE9E-4912-A6FE-547752EF83EB

P356

J.1601-0825.2012.01919.X

P1433

P1476

Biologics in oral medicine: principles of use and practical considerations.

@en

P2093

C Scully

http://www.w3.org/2001/XMLSchema#string

I D O'Neill

http://www.w3.org/2001/XMLSchema#string

P2860

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Treatment with infliximab for a child with Behçet's disease.

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.

EULAR recommendations for the management of Behçet disease.

Rituximab in autoimmune hematologic diseases: not just a matter of B cells.

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank.

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

Late-onset neutropenia following rituximab therapy in rheumatic diseases: association with B lymphocyte depletion and infections.

Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors.

The safety of infliximab infusions in the community setting

P304

525-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1601-0825.2012.01919.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221964885

http://www.w3.org/2001/XMLSchema#string

P698

22420757

http://www.w3.org/2001/XMLSchema#string